Session I: Basic Science and Fundamentals of ElectrophysiologyBasic Electrophysiology Principles for the Clinician Inherited Ion Channelopathies Sinoatrial and Atrioventricular Nodes and His-Purkinje System: Anatomy, Evaluation, Autonomics and Therapy Retrograde Conduction Workshop #1: Electrocardiographic/Electrophysiologic CorrelationsSession II: Invasive Diagnosis and Treatment Use of Entrainment in Supraventricular Tachycardia Principles of Entrainment – Ventricular Tachycardia Techniques of Differentiating SVT Mechanisms: Part I Techniques of Differentiating SVT Mechanisms: Part II Workshop #2: Entrainment and SVT ManeuversCatheter Ablation of Atrial Tachycardia and Atrial Flutter Catheter Ablation of Accessory Pathways Workshop #3: SVT Mechanisms/Maneuvers Catheter Ablation of AV Nodal Reentrant Tachycardia Special Workshop: 12 Lead EKG for PVC and VT Localization Core Principles of Electrophysiology Session III: Invasive Diagnosis and Treatment Ventricular Tachycardia: Ischemic and Nonischemic Cardiomyopathy and Other Unique VT Syndromes Workshop #4: SVT and VT Invasive/Noninvasive Correlation Wide Complex Tachycarias: Idopathic VTs, Bundle Branch Reentry, Antidromic Tachycarias, Mechanisms, Electrocardiographic Manifestations, Invasive Assessment, and Ablation Workshop #5: Invasive/Noninvasive Correlation Session IV: Noninvasive Diagnosis and Treatment Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Electrophysiology of Anti-arrhythmic Drugs: Parts I & II Workshop #6: Electrocardiographic/Electrophysiological Correlations Mechanisms, Pharmacologic, and Non-pharmacologic Treatment of Atrial Fibrillation Biophysics of Catheter Ablation Workshop #7: Electrocardiographic/Electrophysiological Correlations, Atrial Fibrillation, Clinical Scenarios, and Syndromes Session V: Clinical Scenarios/Device Management Device: Evaluation, Management, and Troubleshooting Workshop #8: Device Cases Workshop #9: Arrhythmia Case Studies/Putting It All Together for the Boards Testable Concepts
It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant* financial relationships (for self and for spouse/partner) with an ACCME-defined commercial interest** within the 12 months prior to the disclosure.
Any individual who refuses to disclose financial relationships will be disqualified from participating in HRS educational activities. Employees of ACCME-defined commercial interests can have no role in the planning or implementation of CME activities related to their products or services without a special exception from the HRS Senior Vice President for Education that will be granted only in specific circumstances that meet ACCME requirements.
Relevant Financial Relationships
*Relevant financial relationships are financial relationships in any amount, which occurred in the twelve-month period preceding the time that the individual was asked to assume a role controlling content of the CME activity, and which relate to the content of the educational activity, causing a conflict of interest. The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest.
**a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.
COI Resolution
For all accredited education activities, disclosures are reviewed for potential conflict of interest (COI) and conflicts resolved prior to the activity. If conflicts are identified, the conflict may be resolved by one of the following COI resolution mechanisms:
FACULTY DISCLOSURES
Samuel J. Asirvatham, M.D
Honoraria/Speaking/Consulting Fee: Boston Scientific Corp., BIOTRONIK, Medtronic, Inc., Abbott Laboratories.
Intellectual Property Rights: AliveCor
Kenneth A. Ellenbogen, MD, FHRS
Compensation for Services: Biosense Webster, Medtronic
Fellowship Support: Boston Scientific, Medtronic, Biotronik, Abbott: Honoraria, Lectures, Consulting.
Edward Paul Gerstenfeld, MD, FHRS
Compensation for Services: Medtronic, Inc., Boston Scientific Corp., St. Jude Medical, Boehringer Ingelheim.
Equity Interests/Stock Options – Non-Public: Rhythm Diagnostic Systems Inc.
Research Grants: St. Jude Medical, Biosense Webster, Inc.
Fellowship Support: Medtronic, Inc., Boston Scientific Corp., Biotronik, Biosense Webster, Inc.
Barry London, MD, PhD
Nothing Relevant to Disclose
Francis E. Marchlinski, MD, FHRS
Compensation for Advisory/Consulting Services: Biosense Webster, Inc., Abbott, Boston Scientific Corp., Medtronic, Inc., BIOTRONIK.
Research Grants: Medtronic, Inc., Boston Scientific Corp., BIOTRONIK, Abbott, Biosense Webster.
Fellowship Support: BIOTRONIK, Boston Scientific Corp., Medtronic, Inc., Abbott, Biosense Webster.
Gregory F. Michaud, MD, FHRS
William M Miles, MD, FHRS
EP Fellowship support: Abbott, Biosense-Webster, Biotronic, Boston Scientific, Medtronic
Consultant: Medtronic, Inc.
John M. Miller, MD, FHRS
Compensation for Services: Medtronic, Inc., Boston Scientific Corp., Biosense Webster, Inc., BIOTRONIK, Topera Medical
Consulting Fees/Honoraria: Abbott Electrophysiology/Topera Medical, Biotronik, Boston Scientific Corp., Biosense Webster, Inc., Medtronic, Inc.
Fellowship Support: Medtronic, Inc., Boston Scientific Corp., Biosense Webster, Inc., Biotronik, Inc.
Jeanne E. Poole, MD, FHRS
Consulting Fees/Honoraria: Boston Scientific, Medtronic
Research: Kestra, Inc; Biotronik; AtriCure
William G. Stevenson, MD
Officer, Trustee, Director, Committee Chair, or Any Other Fiduciary Role: American Heart Association
Intellectual Property Rights: Brigham and Women's Hospital, Biosense Webster, Inc.
Honoraria/Speaking/Consulting Fee; Abbott
Gordon F. Tomaselli, MD, FHRS
Consultant: Amgen, Scientific Advisory Board
CME COMPLIANCE SUBCOMMITTEE DISCLOSURES
Samuel J. Asirvatham, MD, FHRS – Honoraria/Speaking/Consulting Fee: Boston Scientific Corp., BIOTRONIK, Medtronic, Inc., Abbott Laboratories. Intellectual Property Rights: AliveCor
Peter F. Aziz MD, FHRS – Nothing to disclose
Marcie G. Berger. MD. PhD, FHRS – Nothing to disclose
Hiroko Beck, MD, FHRS – Nothing to disclose
Scott C. Brancato, MD, FHRS – Nothing to disclose
Scott J. Cox, MS, PAC, CEPS, CCDS – Compensation for Services; ScottCare Inc., Speaker's Bureau; Abbott.
Sandeep K. Goyal, MD, FHRS – Compensation for Services; Biosense Webster, Inc.
Peter A. Noseworthy, MD, FHRS – Nothing to disclose
Atul Prakash, MD, FHRS, CCDS, CEPS-A – Research Grants; BIOTRONIK
HEART RHYTHM STAFF DISCLOSURES
Laurel Blaydes – Nothing to disclose
Russell Werlinich – Nothing to disclose
Tonia Jones – Nothing to disclose
Almaz Aria – Nothing to disclose
Anne Marie Smith, MBA, PMP – Nothing to disclose
Timothy Gregory – Nothing to disclose
Obse Debela – Nothing to disclose